• Veeva

Elite academic institutions are more likely to restrict access to pharmaceutical sales representatives, according to industry research. This trend holds consistent with physicians from highly specialized concentrations, including oncology and nephrology.1 As life sciences’ pipelines continue to shift from small molecules to ones with greater focus on rare diseases, it is critical to understand and engage thought leaders to support scientific exchange leading to improved patient outcomes.
Read more...